08048036315
Leading exporter of Genuine MYCOFIT S 360MG Tablets from India to Singapore - Tampines |Phoenix Exim

1. General Information

Mycofit-S 360 mg Tablet is an immunosuppressive medicine containing mycophenolic acid 360 mg. It is generally prescribed as part of a combination treatment after organ transplantation, particularly for kidney transplantation and, when clinically appropriate, heart or liver transplantation. It reduces certain immune responses that can cause the body to reject a transplanted organ.

Manufacturer/Marketer: Intas Pharmaceuticals Ltd.
Active ingredient: Mycophenolic acid 360 mg (as sodium salt)
Dosage form: Tablet, delayed-release
Therapeutic class: Immunosuppressant
Prescription status: Prescription medicine

For Phoenix Exim, the product can be described for pharmaceutical export enquiries from Nagpur, India to markets including the USA, UK, Australia, Singapore, Canada, South Korea and UAE, subject to each destination's applicable pharmaceutical import and prescription regulations.

2. Product Information

  • Brand: MYCOFIT-S 360 MG
  • Composition: Mycophenolic acid 360 mg, as sodium salt
  • Form: Oral tablet
  • Manufacturer: Intas Pharmaceuticals Ltd.
  • Pack information: Commonly supplied in strips of 10 tablets
  • Category: Immunosuppressant
  • Main indication: Prevention of organ-transplant rejection

Mycofit-S 360 mg is distinct from Mycofit 500 mg, which contains mycophenolate mofetil; the 360 mg Mycofit-S formulation contains mycophenolic acid as the sodium salt.

3. Uses of Mycofit-S 360 mg

Mycofit-S 360 mg is mainly used to prevent rejection following organ transplantation. Depending on the transplant and the patient's treatment plan, it may be used for:

  • Kidney transplant rejection prevention
  • Heart transplant rejection prevention
  • Liver transplant rejection prevention
  • Maintenance immunosuppression following transplantation

It is normally used in combination with other immunosuppressive medicines, according to the transplant specialist's prescription.

4. Benefits of Mycofit-S 360 mg

The principal therapeutic benefit is helping reduce the immune response against a transplanted organ.

Potential benefits include:

  • Helps prevent transplanted-organ rejection
  • Supports continued function of the transplanted organ
  • Helps maintain appropriate immunosuppression after transplantation
  • Can be incorporated into a combination immunosuppressive treatment regimen

The medicine should be used only according to the transplant specialist's instructions because maintaining the correct level of immunosuppression is important.

5. Side Effects

Because Mycofit-S suppresses immune-system activity, it can increase susceptibility to infections and can affect blood-cell counts. Possible adverse effects include:

  • Diarrhea
  • Nausea or indigestion
  • Abdominal discomfort
  • Headache
  • Dizziness
  • Fatigue
  • Rash or acne
  • Fever
  • Urinary or respiratory infections
  • Reduced white blood cell count
  • Anemia
  • Changes in blood chemistry
  • Swelling/edema

Serious or persistent symptoms should be reported promptly to the treating physician.

6. Common Side Effects

Some of the more frequently reported effects include:

  • Diarrhea
  • Nausea
  • Headache
  • Indigestion
  • Abdominal discomfort
  • Infections
  • Low white blood cell count
  • Anemia
  • Fever

The occurrence and severity can vary between patients.

7. How to Use

  • Take Mycofit-S 360 mg exactly as prescribed by the transplant specialist.
  • Swallow the tablet whole with water.
  • Do not crush, chew or break the tablet.
  • Take it at approximately the same time each day.
  • Do not change the dose or discontinue treatment without medical advice.
  • Follow the instructions regarding food consistently; product references differ on whether food is permitted, so the patient's prescribing information and doctor's instructions should take priority.

If a dose is missed, the patient should follow the instructions provided by their transplant team rather than independently doubling the next dose.

8. How Mycofit-S 360 mg Works

Mycofit-S contains mycophenolic acid, which suppresses certain immune cells involved in the body's immune response.

It inhibits an enzyme involved in purine synthesis, which is particularly important for the multiplication of T and B lymphocytes. By reducing the proliferation of these immune cells, the medicine decreases the immune response against the transplanted organ and thereby helps reduce the risk of rejection.

9. Safety Advice

Because this is a potent prescription immunosuppressant, several precautions are important:

  • Prescription use: Take only under specialist medical supervision.
  • Infections: Immunosuppression can increase the risk of bacterial, viral and fungal infections. Report unusual fever, persistent cough, painful urination or other signs of infection.
  • Blood tests: Regular blood monitoring may be required, including checks of blood-cell counts and other laboratory parameters.
  • Pregnancy: Mycophenolate medicines can cause serious fetal harm. Women who can become pregnant require strict pregnancy-prevention and medical counselling according to applicable prescribing guidance.
  • Breastfeeding: Discuss breastfeeding with the treating physician before taking this medicine.
  • Sun exposure: Immunosuppressed patients may have an increased risk of certain skin cancers, so appropriate sun protection is advisable.
  • Vaccinations: Consult the doctor before receiving vaccines, particularly live vaccines.
  • Drug interactions: Tell the transplant specialist about all prescription medicines, OTC medicines and supplements.
  • Do not stop suddenly: Stopping immunosuppressive therapy without medical supervision can increase the risk of transplant rejection.

10. FAQs

Q1. What is Mycofit-S 360 mg used for?
It is an immunosuppressant mainly used with other medicines to prevent rejection of a transplanted organ.

Q2. What is the active ingredient?
It contains mycophenolic acid 360 mg as the sodium salt.

Q3. Is Mycofit-S 360 mg a prescription medicine?
Yes. It should be taken only under appropriate medical supervision.

Q4. Can I stop Mycofit-S when I feel better?
No. Transplant patients should not stop or change their immunosuppressive treatment without their transplant specialist's advice.

Q5. Can Mycofit-S 360 mg cause infections?
Yes. Because it suppresses the immune system, it can increase susceptibility to infections.

Q6. Does it require regular blood tests?
Regular monitoring may be recommended to check blood-cell counts and other parameters during treatment.

Q7. Can Mycofit-S 360 mg be substituted on my own?
No. Different mycophenolate formulations are not automatically interchangeable. Any substitution should be approved by the treating physician.

11. Substitutes for Mycofit-S 360 mg

Potential brands containing comparable mycophenolic acid/mycophenolate sodium 360 mg include:

  • Mycept-S 360 mg
  • Mofetyl-S 360 mg
  • Mycomune-S 360 mg
  • Renodapt-S 360 mg
  • Myplat 360 mg

However, the exact formulation, release characteristics, manufacturer and approved indications should be checked before considering any substitution. A doctor or pharmacist should approve the replacement.

12. SEO & B2B Keywords

Primary keywords:

  • Mycofit-S 360 mg Tablets
  • Mycofit S 360 mg
  • Mycofit-S 360 mg exporter
  • Mycofit-S 360 mg supplier
  • Mycofit-S 360 mg pharmaceutical exporter
  • Mycophenolic acid 360 mg tablets
  • Mycophenolic acid 360 mg supplier
  • Mycophenolate sodium 360 mg tablets
  • Mycophenolate sodium 360 mg exporter
  • Mycofit-S 360 mg manufacturer India

Long-tail B2B keywords:

  • Buy Mycofit-S 360 mg Tablets from India
  • Mycofit-S 360 mg Tablets exporter from Nagpur India
  • Mycofit-S 360 mg pharmaceutical supplier India
  • Mycophenolic acid 360 mg tablets wholesale supplier
  • Mycophenolate sodium 360 mg tablets wholesale exporter
  • Mycofit-S 360 mg tablets international pharmaceutical supplier
  • Mycofit-S 360 mg medicine exporter to USA
  • Mycofit-S 360 mg supplier to UK
  • Mycofit-S 360 mg exporter to Australia
  • Mycofit-S 360 mg supplier to Canada
  • Mycofit-S 360 mg exporter to Singapore
  • Mycofit-S 360 mg supplier to South Korea
  • Mycofit-S 360 mg pharmaceutical exporter to UAE
  • Mycofit-S 360 mg transplant medicine supplier
  • Mycofit-S 360 mg immunosuppressant medicine exporter
  • Mycophenolic acid tablets exporter from India
  • Prescription transplant medicines exporter India
  • Organ transplant immunosuppressant supplier India
  • Mycophenolate sodium medicine supplier for international buyers
  • Phoenix Exim Mycofit-S 360 mg exporter Nagpur India
Aug 19th, 2026 3:27 PM

Keywords